PMID: 12771025May 29, 2003Paper

AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression

Carcinogenesis
Jun LiYi Sun

Abstract

In an effort to search for genes responsible for cell growth arrest and/or apoptosis associated with p53 signaling pathways, we profiled a human lung carcinoma line H1299, expressing a temperature-sensitive p53 (V138) against Affymetric human U95Av2 GeneChip A, consisting of 12 000 genes. 133 genes were identified that were either induced or repressed in response to p53-dependent cell growth arrest and apoptotic conditions. Among them, the beta1 subunit, but not other subunits of the AMP-activated protein kinase (AMPK) was strongly induced. The p53 consensus binding site search in the AMPK-beta1 promoter and the first intron identified four such putative sites. However, p53 failed to bind to any of these sites as assayed by in vitro gel retardation and in vivo chromatin immunoprecipitation. Furthermore, northern analysis showed that induction of this gene is independent of p53, as increased expression of the gene was observed in p53 null H1299/Neo control cells when the temperature was shifted to 32 degrees C. Moreover, a DNA damaging agent, etoposide, also induced beta1 subunit expression in multiple human tumor cells, regardless of p53 status. Thus, the beta1 subunit of AMPK is not a p53 downstream target gene, but can be ind...Continue Reading

Citations

Sep 18, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·F P Kuhajda
Mar 25, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W N WilliamH-Y Lee
May 26, 2012·Cellular and Molecular Life Sciences : CMLS·Tz-Chuen JuYijuang Chern
Jun 22, 2005·Neoplasia : an International Journal for Oncology Research·Jun LiYi Sun
May 10, 2007·Journal of Cellular and Molecular Medicine·Margaret M ShawRobert S Sherwin
Nov 21, 2009·The EMBO Journal·Nicolas HumbertDavid Bernard
Feb 1, 2005·Trends in Pharmacological Sciences·Zhijun LuoNeil B Ruderman
Jan 15, 2016·Acta Biochimica Et Biophysica Sinica·Mingo M H YungDavid W Chan
Sep 11, 2004·Biochemical and Biophysical Research Communications·Xiaoqin XiangZhijun Luo
Aug 4, 2015·Canadian Journal of Physiology and Pharmacology·Anjeza PashajRégis Moreau
Jul 27, 2005·Journal of Chemotherapy·J J GillsJ M Pezzuto
May 23, 2008·Gynecologic Oncology·Walter H GotliebIlan Bruchim
Nov 15, 2003·Current Biology : CB·Angela WoodsDavid Carling
Jan 1, 2013·Computational and Structural Biotechnology Journal·Emily R Roberts, Kelly Jean Thomas
Feb 4, 2014·Cancer Letters·Brandon FaubertRussell G Jones
Oct 25, 2016·Biochimica Et Biophysica Acta·Ji ChengWenyi Wei
May 26, 2017·Molecular Oncology·Vanessa P HoudeGregory R Steinberg
Aug 5, 2018·Journal of Cellular Physiology·Mahdi HatamipourAmirhosein Sahebkar
Mar 15, 2019·Nature Reviews. Drug Discovery·Gregory R Steinberg, David Carling
May 24, 2019·Cell Biology and Toxicology·Tingting FangXiawei Wei
May 10, 2015·Molecular Cancer Research : MCR·Giorgia ZadraMassimo Loda
Jan 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W N WilliamH-Y Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis